AstraZeneca Balance Sheet Health
Financial Health criteria checks 3/6
AstraZeneca has a total shareholder equity of $39.2B and total debt of $28.5B, which brings its debt-to-equity ratio to 72.8%. Its total assets and total liabilities are $101.1B and $62.0B respectively. AstraZeneca's EBIT is $10.4B making its interest coverage ratio 11.4. It has cash and short-term investments of $5.9B.
Key information
72.8%
Debt to equity ratio
US$28.52b
Debt
Interest coverage ratio | 11.4x |
Cash | US$5.86b |
Equity | US$39.17b |
Total liabilities | US$61.95b |
Total assets | US$101.12b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: AZN's short term assets ($25.1B) do not cover its short term liabilities ($30.5B).
Long Term Liabilities: AZN's short term assets ($25.1B) do not cover its long term liabilities ($31.4B).
Debt to Equity History and Analysis
Debt Level: AZN's net debt to equity ratio (57.9%) is considered high.
Reducing Debt: AZN's debt to equity ratio has reduced from 149.4% to 72.8% over the past 5 years.
Debt Coverage: AZN's debt is well covered by operating cash flow (36.3%).
Interest Coverage: AZN's interest payments on its debt are well covered by EBIT (11.4x coverage).